188 related articles for article (PubMed ID: 34260541)
1. Clinical significance of YAP1 and TAZ in esophageal squamous cell carcinoma.
Liu L; Lu Z; Hu X; Su T; Su L; Pu H
Medicine (Baltimore); 2021 Jul; 100(28):e26597. PubMed ID: 34260541
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of lymph node metastasis in esophageal squamous cell carcinoma.
Wang H; Deng F; Liu Q; Ma Y
Pathol Res Pract; 2017 Jul; 213(7):842-847. PubMed ID: 28554754
[TBL] [Abstract][Full Text] [Related]
3. Expression and clinical significance of REPS2 in human esophageal squamous cell carcinoma.
Zhang H; Duan CJ; Zhang H; Cheng YD; Zhang CF
Asian Pac J Cancer Prev; 2013; 14(5):2851-7. PubMed ID: 23803043
[TBL] [Abstract][Full Text] [Related]
4. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
[TBL] [Abstract][Full Text] [Related]
5. Porphyromonas gingivalis promotes progression of esophageal squamous cell cancer via TGFβ-dependent Smad/YAP/TAZ signaling.
Qi YJ; Jiao YL; Chen P; Kong JY; Gu BL; Liu K; Feng DD; Zhu YF; Ruan HJ; Lan ZJ; Liu QW; Mi YJ; Guo XQ; Wang M; Liang GF; Lamont RJ; Wang H; Zhou FY; Feng XS; Gao SG
PLoS Biol; 2020 Sep; 18(9):e3000825. PubMed ID: 32886690
[TBL] [Abstract][Full Text] [Related]
6. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
Zhang Y; Liu YP; Du K; Wang H; Wang XL
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
[TBL] [Abstract][Full Text] [Related]
7. The Expression and Prognostic Value of FGF2, FGFR3, and FGFBP1 in Esophageal Squamous Cell Carcinoma.
Zhang W; Zhou Y; Li C; Xu S; Li M; Liu W; Ma Y; Wang H
Anal Cell Pathol (Amst); 2020; 2020():2872479. PubMed ID: 33381388
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
[No Abstract] [Full Text] [Related]
9. [Expression and clinical significance of DAPK1 and CD147 in esophageal squamous cell carcinoma].
Wan Y; Wu XY
Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):44-8. PubMed ID: 22490855
[TBL] [Abstract][Full Text] [Related]
10. The tumor-suppressive role of BATF2 in esophageal squamous cell carcinoma.
Han T; Wang Z; Yang Y; Shu T; Li W; Liu D; Li P; Qi R; Ren Y; Li L; Liu H; Zhang S; Zhang L
Oncol Rep; 2015 Sep; 34(3):1353-60. PubMed ID: 26135942
[TBL] [Abstract][Full Text] [Related]
11. OTUB2 Regulates YAP1/TAZ to Promotes the Progression of Esophageal Squamous Cell Carcinoma.
Liu L; Cheng H; Ji M; Su L; Lu Z; Hu X; Guan Y; Xiao J; Ma L; Zhang W; Pu H
Biol Proced Online; 2022 Jul; 24(1):10. PubMed ID: 35850645
[TBL] [Abstract][Full Text] [Related]
12. Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma.
Guo J; Yang Q; Wei S; Shao J; Zhao T; Guo L; Liu J; Chen J; Wang G
BMC Cancer; 2022 Jul; 22(1):745. PubMed ID: 35799142
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathological and prognostic significance of the expression of ADAM17 mRNA and protein in esophageal squamous cell carcinoma].
Liu HB; Yang QC; Shen Y; Zhu Y; Zhang XJ; Chen H
Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):361-5. PubMed ID: 24054013
[TBL] [Abstract][Full Text] [Related]
14. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
15. Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.
Ren HZ; Pan GQ; Wang JS; Wen JF; Wang KS; Luo GQ; Shan XZ
Dig Dis Sci; 2010 Sep; 55(9):2552-60. PubMed ID: 20108042
[TBL] [Abstract][Full Text] [Related]
16. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features.
Wang WS; Zhong HJ; Xiao DW; Huang X; Liao LD; Xie ZF; Xu XE; Shen ZY; Xu LY; Li EM
Dis Esophagus; 2010 Aug; 23(6):512-21. PubMed ID: 20095995
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics Analysis Reveals a Novel Prognostic Model for Esophageal Squamous Cell Carcinoma.
Yang H; Chen Y; Huang X; Gu Y; Chen Z; Mao W
Int J Med Sci; 2024; 21(7):1213-1226. PubMed ID: 38818465
[No Abstract] [Full Text] [Related]
18. Gli1 interacts with YAP1 to promote tumorigenesis in esophageal squamous cell carcinoma.
Wang C; Cheng L; Song S; Wu S; Sun G
J Cell Physiol; 2020 Nov; 235(11):8224-8235. PubMed ID: 31957872
[TBL] [Abstract][Full Text] [Related]
19. CD82/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-β1.
Zeng TD; Zheng B; Zheng W; Chen C
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5928-5937. PubMed ID: 30280774
[TBL] [Abstract][Full Text] [Related]
20. Expression of long non-coding RNA ZEB1-AS1 in esophageal squamous cell carcinoma and its correlation with tumor progression and patient survival.
Wang YL; Bai Y; Yao WJ; Guo L; Wang ZM
Int J Clin Exp Pathol; 2015; 8(9):11871-6. PubMed ID: 26617942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
